🇺🇸 FDA
Patent

US 6479465

Methods of treating colitis using STAT-4 anti-sense oligonucleotides

expired A61KA61K38/00A61K48/00

Quick answer

US patent 6479465 (Methods of treating colitis using STAT-4 anti-sense oligonucleotides) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K48/00